Regenxbio Inc (RGNX)
16.11
-0.92
(-5.40%)
USD |
NASDAQ |
Apr 18, 16:00
16.10
-0.01
(-0.06%)
After-Hours: 20:00
Regenxbio Profit Margin (Quarterly): -283.1% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -283.1% |
| September 30, 2023 | -214.0% |
| June 30, 2023 | -360.7% |
| March 31, 2023 | -348.4% |
| December 31, 2022 | -191.2% |
| September 30, 2022 | -284.7% |
| June 30, 2022 | -208.8% |
| March 31, 2022 | -345.3% |
| December 31, 2021 | 73.75% |
| September 30, 2021 | -189.8% |
| June 30, 2021 | -261.6% |
| March 31, 2021 | -265.5% |
| December 31, 2020 | -215.6% |
| September 30, 2020 | 8.89% |
| June 30, 2020 | -203.8% |
| March 31, 2020 | -226.9% |
| December 31, 2019 | -224.9% |
| September 30, 2019 | -235.3% |
| June 30, 2019 | -18.49% |
| Date | Value |
|---|---|
| March 31, 2019 | -3.65K% |
| December 31, 2018 | 10.56% |
| September 30, 2018 | -361.9% |
| June 30, 2018 | 26.46% |
| March 31, 2018 | 78.74% |
| December 31, 2017 | -784.2% |
| September 30, 2017 | -1.55K% |
| June 30, 2017 | -220.6% |
| March 31, 2017 | -4.83K% |
| December 31, 2016 | -1.16K% |
| September 30, 2016 | -14.52K% |
| June 30, 2016 | -607.9% |
| March 31, 2016 | -2.74K% |
| December 31, 2015 | -116.4% |
| September 30, 2015 | -643.2% |
| June 30, 2015 | -461.5% |
| March 31, 2015 | -622.8% |
| December 31, 2014 | -203.5% |
| September 30, 2014 | -371.2% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-360.7%
Minimum
Jun 2023
73.75%
Maximum
Dec 2021
-210.3%
Average
-224.9%
Median
Dec 2019
Profit Margin (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | 11.51% |
| Amgen Inc | 9.36% |
| Gilead Sciences Inc | 20.09% |
| AbbVie Inc | 5.75% |
| Bristol-Myers Squibb Co | 15.35% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -63.89% |
| Return on Assets | -37.95% |
| Return on Invested Capital | -63.89% |
| Gross Profit Margin (Quarterly) | 49.41% |
| Operating Margin (Quarterly) | -287.7% |
| Return on Net Operating Assets | -108.8% |